zalcitabine has been researched along with Experimental Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haugen-Strano, A; Schippert, A; Söderkvist, P; Wiseman, RW; Zhuang, SM | 1 |
1 other study(ies) available for zalcitabine and Experimental Neoplasms
Article | Year |
---|---|
Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas.
Topics: Animals; Butadienes; Carcinogens; Carrier Proteins; Cell Cycle Proteins; CpG Islands; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; DNA, Neoplasm; Homozygote; Lymphoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Point Mutation; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic; Sequence Analysis, DNA; Tumor Suppressor Proteins; Zalcitabine | 1998 |